The recombinant a and b subunits for human coagulation factor XIII were transfected into Chinese hamster ovary (CHO) cells. CHO cells were amplified and selected with methotrexate in adherent cultures containing serum, and CHO 1-62 cells were later selected in protein-free medium. To develop a recombinant factor XIII production process in a suspension culture, we have investigated the growth characteristics of CHO cells and the maintenance of factor XIII expression in the culture medium. Suspension adaptation of CHO cells was performed in protein-free medium, GC-CHO-PI, by two methods, such as serum weaning and direct switching from serum containing media to protein-free media. Although the growth of CHO cells in suspension culture was affected initially by serum depletion, cell specific productivity of factor XIII showed only minor changes by the direct switching to protein-free medium during a suspension culture. As for the long-term stability of factor XIII, CHO 1-62 cells showed a stable expression of factor XIII in protein-free condition for 1000 h. These results indicate that the CHO 1-62 cells can be adapted to express recombinant human factor XIII in a stable maimer in suspension culture using a protein-free medium. Our results demonstrate that enhanced cell growth in a continuous manner is achievable for factor XIII production in a protein-free medium when a perfusion bioreactor culture system with a spin filter is employed.
Introduction
amine the biological roles of the factor by using animal cell expression system. The a subunit of facior Human coagulation factor XIII, known as also plasma XIII displays features of a typical cytoplasmic protransglutaminase or fibrin stabilizing factor, circulates tein, and on the other hand, the b subtinit has a typical in blood as a heterotetramer consisting, of two sequence for secretion (Ichinose et al. 1986 ). In a cata]ytic a and two noncatalytic b subunits (Schwartz study on the release of the a, b subunits of factor XIIÏ et al. 1973; Ichinose et al. 1986; Broker et al. 1991) .
expressed in BHK cells, the a subunit was found to be Factor XIII is a proerizyme, which is actixated by released from cells only as a consequence of cell thrombin that is generated at the final stage of the injury at least in vitro (Kaetsu et al. 1996 ). blood coagulation cascade. A deficiency of factor XIII Recently the expression of human factor XIII was in humans results in a life-long bleeding tendency, achieved in several host cells, Eseherichia coli, Chispontaneous abortion, and abnormal wound healing.
nese hamster ovary (CHO), Baby hamster kidneÿ Although the secretion pathway of factor XIII is not (BIlK) and yeast (Broker et al. 1991 ; Tharaud et al. clearly known, studies have been performed to ex-1992; Kaczmarek et al. 1995; Kaetsu et al. 1996) . The yeast cell expression system was shown to be an Cell line and cell culture efficient system for the expression of recombinant factor XIII, resulting in a high yield. Although the The anchorage-dependent CHO cells which express animal cell culture system is hampered by slower cell recombinant human factor XIII were constructed growth, lower cell density and lower production rate using the following transfection strategy. The dhfr 2 than that of yeast, the expression of factor XIII in an negative (dhfr host CHO cell line, DG44, was grown animal cell culture system is still believed to be the in Minimal essential medium alpha modification method of choice as for many other human recombi-(MEM alpha, Sigma, USA) with 10% dialyzed fetal nant proteins for commercial production. CHO cells bovine serum (Sigma, USA). The CHO cells were have been widely used for expression of human co-transfected with 10 mg of each of the expression therapeutic recombinant proteins such as blood clotplasmids coding the a (with dhfr gene) and b subunits ting factors, cytokines, growth factors, immuno-(without the dhfr gene) of factor XIII using  globulins, and thrombolytics (Kaufman et al. 1988 ; Lipofectin (Life Technologies, USA). The Hind III Boedeker 1992; Hayter et al. 1992; Tonouchi et al. 59 end, containing the leader sequence, Apa I 139 end 1992; Bekkari et al. 1994; Castro et al. 1995; Kauf- of the 2.3 kb codin region of the a subunit cDNA of man et al. 1985) . The wide use of CHO cells has been factor XIII, was constructed by RT-PCR (reverse due to several advantages: relative stability and high transcriptase polymerase chain reaction) from human expression levels, efficient posttranscriptional proliver RNA. The 2.2 kb coding region for the b subunit cessing, glycosylation of recombinant proteins, easy cdNA was constructed from human placental RNA FDA approval for commercial production, and the with the same cloning site. The expression vectors for scale up capacity using serum-free and protein-free the a subunit and b subunit were named pRC-CMV medium.
(dhfr) / XIlla and pRC-CMV/ Xlllb. The construction In order to develop a CHO based production system of expression plasmids was carried out by using an for human recombinant coagulation factor XIII, CHO established protocol (Jin et al. 1993) . Both plasmids cells expressing the a and b subunits of recombinant contained the neo gene as selection marker. After factor XIII were selected in a stationary culture in transfection, cells were harvested and aliquots of 100 serum containing medium. Up to now, the expression ml were distributed in 96 well plates it a cell cormeen-4 of factor XIII in a suspension culture using proteintration of 1 3 10 cells per well. The cells were 21  free media has not been reported, and it has been cultivated in the presence of 5 mg ml G418 (Life difficult to get factor XIII secreted into the culture Technologies, USA) for the selection of transfectants. media. In addition, it is not easy to culture adherent In order to obtain stable clones, a selective agent, animal cells on a large scale because of cumbersome methotrexate (MTX) was added to the each well. handling, higher contamination risk and high labor During the MTX selection and adaptation with incost. Thus, the development of a serum-free or creasing MTX concentration from 20 nM, 80 nM, 320 protein-free culture medium is a key point for the nM, to 1 mM, MTX-resistant subclones for factor large-scale industrial production of a target protein XIII production were screened by an ELISA and by a from animal cell culture based on the use of CHO modified biological activity assay. Finally, the 1-62 cells, because under serum-free conditions these cells clone was obtained from the selection of a single cell grow in suspension and also because the biological subclone. The selected CEO 1-62 cells expressing safety is increased.
factor XIII were maintained in MEM alpha with In this study, we developed a protein-free medium 5%FBS and 1 mM MTX at 37 8C under a humidified for a CHO cell suspension culture. The adaptation of atmosphere containing 5% CO . Adherent cell cul-2 2 CHO cells to suspension culture was performed by tures in 175-cm T-flask (Nunc, Denmark) were weaning or direct switching to serum-free conditions. subcultured twice per week by treatment with a 0.1% Via evaluation of long-term stability of factor XIII trypsin solution. expression in a protein-free suspension culture, it was possible to perform a scale-up. Thus, a scale-up Protein-free media for CHO cell culture culture of CHO cells in a stirred tank bioreactor with a spin-filter was successfully performed by using a
The protein-free medium, GC-CHO-PI, was deprotein-free medium. This procedure will allow highveloped for suspension culture of CHO cells by the density cultures of CHO cells for the production of Green Cross company (Korea) The GC-CHO-PI recombinant proteins.
medium formulated for optimal cell growth and pro-tein production in CHO cells was manufactured by supernatants were stored at 270 8C for further analySigma-Aldrich (USA) under cGMP conditions. This ses. protein-free medium was originally designed as medium free of animal-derived components. The
In vitro bioassay of factor XIII basal medium consisted of a modification of Dulbecco's Modified Eagle medium and Ham's F12 medium A modified factor XIII assay method was used to without hypoxanthine, thymidine, and phenol red.
determine the enzyme activity from CHO cell lysates This basal medium for protein-free culture of CHO that express factor XIII. For the preparation of 1% cells was supplemented with additional amino acids, (w / v) factor XIII free monomer solution, 4 g of vitamins, and serum-free supplements, such as lipoic fibronectin was dissolved in 400 ml of citrate buffer acid, linoleic acid, hydrocortisone, trace elements, (50 mM, pH 6.8), and 100 ml thrombin was added to sodium selenite, and sodium pyruvate. The osmolality producea fibrin clot. The chopped fibrin clots were was controlled at 290 6 10 mOsm per kg with sodium washed with 100 ml of citrate buffer (50 mM, pH6.8) chloride. The protein-free medium was finally supuntil soluble protein was nonexistent by centrifuga- plemented with 01% Pluronic F68 for suspension tion at 3,000 g (Beckman Avanti M J-25 centrifuge, culture.
USA), After discarding the supernatant, the pellet was dissolved in 5 M urea by stirring gently. The solution Perfusion culture system was dialyzed 3 times against 2 mM acetic acid and 21 adjusted to 20 mg ml . The solution was then After CHO cells expressing the a and b subunits of lyophilized, at which point it was ready to be used for recombinant factor XIII were adapted for suspension assay by dissolving in 2 ml of 2 mM acetic acid. growth in protein-ftce medium, spinner cultures
The CHO cell lysates were prepared from cultured (flasks from BelIco, USA) of 1-62 cells were started CHO cells by centrifugation at 8,000 g for 20 mm.
at an initial concentration of 3-4 3 10 cells ml The pellets were dissolved in the 0.01 m Tris-acetate using an agitation of 50 rpm (biological stirrer from buffer (pH 8.0) and disrupted by freezing and thawThermolyne, USA). All cultures were supplemented ing. The cell lysates were harvested by centnifugation with 1 mM MTX. After the cell density reached about again, and the original culture supernatants were 1 3 l0 cells ml , the culture medium was replaced mixed with cell lysates. After the standard factor XIII by fresh protein-free medium at 85% of the working human plasma was diluted with 0.15 M NaCl / O.4%
21
volume. albumin solution to 0 mU ml 0 mU ml , 5 mU
Perfusion cultures were performed using a 10-l ml , 10 mU ml , 20 mU ml , 25 mU ml . 100  working volume stirred tank bioreactor (BIOSTAT ml of 1% (w / v) factor XIII free fibrin monomer ED, B.Braun Biotech Inc., Germany) equipped with a solution were added to 200 ml of each standard stainless steel spin filter (pore size 15 mm) mounted solution and samples in the test tubes. Thrombin was on the agitation shaft. Fresh medium was dispensed prepared by dilution of thrornbin (250 U lyophilized into extra-spin filter space and cell-free supernatant powder) with four parts of 1 M Tris-acetate (pH8.0) was withdrawn from the spin filter. Seed cells were buffer solution containing 0.125 M CaCl and one 2 prepared in 3 l spinner flasks and inoculated into the part of 0.15 M NaCl in the 0.4% albumin solution into bioreactor. A digital control unit (DCU) system was final 2 ml. After incubation for 1 hr at 37 8C 3 ml of used to control the pH, agitation, dissolved oxygen 1% (w / v) monochloroacetate solution was added to and temperature. The composition of the culture each tube. The concentrations of dissolved fibrin medium was the same as that used in the spinner flask solution were inversely correlated with the increasing cultures. The perfusion was initiated after the cell level of FXIII standard.
6 21 density has reached about 1 3 10 cells ml by adjusting the pumping rate of peristaltic pumps. DisOther asays solved oxygen (D.O.) was maintained at 40% of air saturation at the atmospheric pressure, and the pH During the incubation period, samples from cell culvalue was maintained at 7.1 by adding CO to the gas turse were taken periodically for microscopic exami-2 stream or by adding a NaHC0 solution to the nation and for determing the cell and metabolite 3 medium. Samples were taken twice daily for the concentrations.Viable cells were counted by using the determination of glucose and lactate concentration trypan blue dye exclusion method. Quantitative estiand the cell density. Samples were centrifuged and the mations of the residual glucose concentration and the produced lactic acid concentration were carried out using an YSI Biochemical analyzer (YSl 2700, USA). The arrimonia concentration was determined by UV detection using L-glutamate dehydrogenase kit (Sigma 171-A, USA).
Results and discussion

Cell growth and Factor Xlll expression in static culture
We have investigated the cell growth characteristics 2 of recombinant CHO 1-62 cells in 175-cm T-flasks using MEM alpha medium containing serum. CHO cells were inoculated at a cell density of 1 3 104 cells 2 2 per cm and 2 3 104 cells per cm in medium containing different concentrations of FBS (0.5%, 1%, 2%, 3%, 4%, or 5%) and cultured in a static mode. As shown in Figure 1 , cell growth rate and maximum cell concentration were increased with an increase in the serum concentrations regardless of the inoculation size, and cultures containing 4% and 5% FBS showed on the cell growth of CHO 1-62 cells in adherent cultures. The culture time to obtain maximum cell growth was reduced with higher inoculurn and higher media. For suspension culture, adaptation to serumserum concentrations (data not shown). This result free and suspension culture is often required. We have shows that recombinant CHO 1-62 cells in static investigated the expression of recombinant factor XIIl culture have a typical cell growth characteristic, dein a static culture of 1-62 cells by using several pendent on the inoculum size and the serum concommercialized serum-free and protein-free media as centration, Hence, 1-62 cell growth could be optiwell as the GC-CHO-PI medium. The CHO 1-62 4 mized by adequate determination of the inoculum size cultures were started with a concentration of 2 3 10 2 and serum concentration. Adherent cultures were cells per cm in MEM alpha supplemented with 5% typically practiced in batch mode without pH control.
FBS. When cell cultures were above 90% confluency, Recently, cell culture media manufacturers comthe culture medium was replaced by various media, mercialized several protein-free media for CHO cells, such as CHO-S-SFM lI (Life Technologies, USA), ீ and several pharmaceutical companies producing, HyQCCM5 (Hyclone, USA), Ex-Cell 301 (JRH recombinant therapeutic proteins for human use have Bioscience, USA), GC-CHO-PI, and MEM alpha with developed their own protein-free media. Nevertheless, 5% FBS. The relative expression levels of factor XIII there have been few reports on protein-free suspenin all cultures, with exception of the culture done in ீ sion culture media for industrial production of recomEx-Cell 301 medium, were a little bit higher than binant human therapeutic proteins from CHO cells.
that in serum supplemented medium (Figure 2 ). This Although, CHO cell lines are generally cultured in indicates that the expression of factor XIII in static adherence, the cells can also be cultured in suspension cultures was not significantly affected by different using commercialized or custom-made protein-free culture media. Factor Xll activity was barely detected in the culture supernatants. This may be due to the adopted to suspension growth in serum-free or characteristics of the a subunit maintained within protein-free medicine. adherent CHO 1-62 cells. However, the b subunit of To adapt 1-62 cells gradually to suspension culture factor XIII was detected in the culture supernatants. and finally to growth in protein-free medium, suspenThese results correspond to the study that the a sion adaptation of these cells to protein-free media subunit of factor XIII displays the features of a typical was performed using a modified weaning method and cytoplasmic protein whereas the b subunit is normally the direct switch method. CHO 1-62 cells grown in secreted into the medium (Ichinose et al. 1986 ).
MEM alpha medium containing serum were adapted to protein-free suspension culture using a two-step procedure; the first step was a sequential reduction of Adaptation to protein-free suspension culture the serum concentration in static culture, and the next step was the selection of CHO cells showing an As suspension culture systems of animal cell offer elevated cell growth rate in suspension culture. Durmany advantages for the production of recombinant ing the weaning period, cultures were performed by proteins, suspension of adherent cells are advantagestepwise reduction of serum from 2.5%, 1.25%, 0.5%, ous for the scale-up production of recombinant proto 0.25% and finally to the protein-free GC-CHO-PI teins. CHO or BHK cell lines for expression of human medium (Figure 3 ). During the adaptation period to therapeutic recombinant proteins are anchorage-desuspension growth, cell aggregates of more than 10 pendent, and suspension cultures of these cells using cells were removed by precipitation. Subsequently, serum and serum-free media have been conducted for the cell suspension was centrifuged at 1,000 rpm for 5 the purpose of industrial production of recombinant min, and the pellet was resuspended with the reduced proteins. A recent study indicates that engineering the serum medium or protein-free medium. Samples of regulatory structure of the mammalian cell cycle is an each culture were collected for the factor XIII assay. alternative method for suspension culture adaptation Cells were inoculated into 4-5 parallel cultures for 5 21
in the absence of serurn (Lee et al. 1996) . The each passage at 4 3 10 cells ml in the GC-CHO-PI adaptation of cells to cultivation in serum-free medium containing different scrum concentrations, medium is usually achieved by gradual weaning. and the culture showing the highest population douDespite these possibilities, not all cell ;ines are bling in the suspension culture was selected and subcultured in fresh medium. Although the cell growth rate decreased with decreasing serum con-
21
centrations (from 0.031 h to 0.024 h ) during gradual adaptation to medium with reduced serum concentrations, cell viability remained high at about 93-97%. After 15 subcultures (approximately 48 population doubling levels) the CHO 1-62 cell line was successfully adapted to growth in the protein-free medium, GC-CHO-PI. Although we had conducted similar procedures to adapt CHO 1-62 cells to other commercialized serum-free or protein-free culture media, such as CHO-S-SFM II, HyQ-CCM5 or ExCellீ 325 PF-CHO, 1-62 cells failed to adapt to growth in the absence of serum (data not shown).
In general, most commercial serum-free or proteinfree media cannot support cell growth after a direct switch from adherent culture in serum-containing (0.034 h ). Using these adapted cells, the stable long-term expression of factor XIII was evaluated in protein-free suspension cultures.
Stable expression of factor XIII in suspension culturse
The CHO cells adapted to serum-free condition should maintain the characteristics of importance, i.e., culture process. In the case of the adapted CHO cells, productivity, gene copy number and amount of inoculum for suspension cultures in spinner flasks.
mRNA cording for the recombinant protein to be Before inoculation, by using the protein-free GCproduced were maintained at the same levels as in the CHO-PI medium the culture medium of adherent original cell. However, in unstable subclones, gene cultures was changed everyday for one week. This copy number and the amount of mRNA decreased was done for adapting CHO 1-62 adherent cells to rapidly, and reversions in the dhfr locus in CH0 cells growth in protein-free medium without Pluronic Fhave been reported. It was also important to monitor  68 . The cell morphology changed gradually a from the yield of the product for each culture in order to typical epithelial-like to a ''round''. Morphology after verify that the suspension batch did not affect the 7 changes of the medium, the CHO 1-62 cells had a production. After adaptation of the cells to growth in spherical shape and were slightly attached on the protein-free suspension culture, we determined cell surface of the T-flask and spherical single cells and growth and factor XIII productivity in long-term small aggregates were left suspended in the medium.
cultures using the GC-CHO-PI medium supplemented These floating cells were then harvested by pipetting with 1 mM MTX. and used as inoculum for protein-free suspension
The CHO 1-62 cells, adapted to the protein-free culture. In each passage, suspension cultures showing an increased cell growth were selected and subcultured in the subsequent suspension culture using the protein-free medium. The selection method was carried out repeatedly during 10 passages. Initial cell concentration was decreased step by step from 6 3 5 21 21
10 cells ml to 2 3 10 cells ml . During adaptation to suspension growth in the protein-free GC-CHO-PI medium, cell growth decreased slightly with each passage, however, the viability stayed at about 91-96% (data not shown). CHO 1-62 cells grown in adherent culture did not require a weaning process to get to suspension growth in the protein-free medium. After 10 passages, CHO 1-62 cells have completely adapted to protein-free suspension culture using the GC-CHO-PI medium (Figure 4 ). It can be more suspension culture medium, were inoculated at a therefore a higher reactor productivity, a stirred tank 5 21 concentration of 3 3 10 cells ml in 100-ml spinner bioractor equipped with a spin filter was used in this flasks (250 ml; working volume, 100 ml) and the study. After comparison of spin filters with different spinners were continuously stirred at 60 rpm. After a pore sizes, a spin filter with a pore size of 15 mm was 6 21
cell density of about 1 3 10 cells ml was obtained, chosen for the suspension cultures of CHO 1-62 cells cells were harvested and new culture was initiated at a using the GC-CHO-PI protein-free medium.
5 21 5 concentration of 3 3 10 cells ml . This repeated After inoculation at a concentration of 3 3 10 cells 21 batch mode was performed up to 20 passages (approxml , the 10-l bioreactor was operated for 3 days in a imately 1000 h), As shown in Figure 5, h . This result indicates that growth of CHO 1-62 the perfusion culture. The residual glucose concencells and expression of factor XIII were maintained tration was controlled at 35 mM, which equals to during a long-terns suspension culture using the GCapproximately 70% of its concentration in a fresh CHO-PI protein-free medium. Therefore, CHO 1-62 medium, and the lactate produced was maintained at cells may be applied for large-scale suspension cul-7-8 mM. In general, other authors (Hayter et al. 1992; tures. Linz et al. 1997) had set the residual glucose concentration in fed-batch or perfusion cultures at much Protein free Perfusion culture lower levels in order to reduce the production of lactate, which is often considered as an inhibiting In principle, a perfusion bioreactor retains cells inside, factor for cell growth in animal cell culture. However, while conditioned medium is constantly replaced by by maintaining high glucose concentration, we could fresh medium. The interest of the spin filter technolosuccessfully control the lactic acid concentration gy is its ability to retain cells and to increase the cell below 10 mM, which is not a limiting concentration density in the bioreactor. In recent reports, perfirsion for cell growth (results not shown). Using the perfuculture systems have been used for high-density culsion rate chosen no amino acid limitations were tures of CHO cells for producing recombinant proobserved (data not shown). Figure 6 presents the teins in serum-free media (Searles et al. 1994; Sina- results from the 10-l perfusion run, which was opercore et Konstantinov et al. 1996; Lee et al. ated over two weeks using protein-free medium. 1996). In batch suspension culture using the proteinApproximately 200 l of culture filtrates were harfree medium GC-CHO-PI, maximal cell densities of vested from the 10-l bioreactor cultured in perfusion 6 21 approximately 3.4 3 10 cells ml were obtained mode. Cell density kept increasing as perfusion 5 when the cultures were inoculated with 3 3 10 cells brought in fresh medium and carried away the spent 21 ml . In order to achieve higher cell densities and medium. After 1 week of culture, cells formed a number of small sized aggregates. As time went on, the size of cell-aggregates enlarged to reach 10-20 cells, with large aggregates containing up to 50 cells. As shown in Figure 6 , CHO 1-62 cells were able to 7 reach a maximurn cell density of more than 1.7 3 10 21 cells ml , which is an approximately 5-fold increase in comparison to the batch culture. Glucose and lactate levels were monitored throughout the culture as indicators for perfusion rate adjustment. Although the expression level of factor XIII secreted to culture supernatant was low with respect to the high cell density, factor XIII expression was maintained at 21 around 0.5 unit ml of culture supernatant during the perfusion operation (Figure 7 ). This indicates that recombinant factor XIII can be released successfully into the culture supernatant in a perfusion culture system. The reason for the rather low titer is that the a subunit of factor XIII is only released from dying cells. Although cell viability was maintained at above 90% during the perfusion culture, the number of dead increased with culture time, and after 256 h of culture the concentration of dead cells stayed stable at 0.8-6 21
1.6 3 10 cells ml . These results correspond to the release data of factor XIII in BHK cell culture (Kaetsu et al. 1996) , in which a factor XIII activity of 1.5-2.5 21 units ml from lysed cells was detected.
Conclusions
The CHO 1-62 cells were selected for the expression of recombinant human coagulation factor XIII in adherent cultures containing serum. To develop a factor XIII production process using a suspension culture system, we have investigated the growth and factor XIII expression characterstics of CHO cells for adaptation to protein-free suspension culture. CHO 1-62 cells did not require weaning steps for adaptation to suspension growth in the GC-CHO-PI protein-free medium when adapting adherent cells to the proteinfree medium. The cell specific productivity of factor XIII underwent only minor changes by direct adaptation to protein-free medium. The GC-CHO-PI protein-free medium was adequate for suspension culture of CHO 1-62 cells and expression of factor protein-free GC-CHO-PI medium can be used for the long-term suspension cultures of CHO cells for the production of factor XIII. The cells could be subcultured serially in the protein-free medium and achieve the same cell growth, indicating true adaptation of the cells. In a large-scale suspension culture using a spinfilter perfusion culture system, the a subunit of factor III was released from cells as a consequence of increased cell death. The ability of the recombinant CHO 1-62 cells to multiply in protein-free culture greatly facilitated the scale-up of the perfusion culture. The efficient expression of factor XIII in the perfusion culture will be further studied by controlling cell viability and by supplementing with secretion factors.
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